Eurofins Discovery
Dr. Marc Schulte is a seasoned professional in the field of drug discovery services, currently serving as the Business Development Manager at Eurofins Discovery since April 2019. In this role, Dr. Schulte manages a multi-million dollar portfolio encompassing integrated services such as Pharmacology, ADME-Tox, Safety, Translational, and Chemistry Services, leading up to IND filing. Prior to this position, Dr. Schulte held various key roles including Key Account Manager at DiscoverX Corporation, Sales Manager at Indivumed GmbH and Cellectis, and Molecular Biology Sales Specialist at Thermo Fisher Scientific. Dr. Schulte's academic background includes a PhD from Christian-Albrechts-Universität zu Kiel, focusing on the structure and regulation of ADAM Metalloproteases, as well as a Diplom in Biology from Technische Universität Braunschweig.
This person is not in any offices
Eurofins Discovery
Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, lasting improvements in human health. Join our dynamic team! View open positions: https://www.eurofinsdiscovery.com/about-us